Skip to main content

Table 3 Modified plaque and bleeding indices, probing depth and crestal bone loss around implants

From: Levels of whole salivary advanced glycation end products and interleukin-17 and peri-implant clinical and radiographic status in patients with osteoporosis at 6-years’ follow-up

Peri-implant parameters

Patients with osteoporosis

Patients without osteoporosis (controls)

P value*

Clinical

Modified bleeding index

0.08 ± 0.0006

0.1 ± 0.0003

0.16

Modified plaque index

0.2 ± 0.005

0.3 ± 0.002

0.14

Probing depth (in mm)

1.06 ± 0.04 mm

1.2 ± 0.002 mm

0.11

Radiologic

Crestal bone loss (mesial) (in mm)

0.3 ± 0.005 mm

0.2 ± 0.005 mm

0.18

Crestal bone loss (distal) (in mm)

0.2 ± 0.003 mm

0.3 ± 0.007 mm

0.16

  1. *Statistical comparisons among patients with and without osteoporosis